Oncotarget’s Top 10 Papers in 2022 (Crossref Data)
Crossref is a non-profit organization that logs and updates citations for scientific publications. Each month,... read more
February 22, 2023
Tagged: Oncotarget
Controlling Glycolytic Flux: Therapy Challenges and Solutions
In a new editorial paper, researchers from the University of Oxford explore challenges and potential... read more
February 16, 2023
The Importance of CD56 in the Fight Against Multiple Myeloma
In a new Oncotarget editorial, researchers discussed their study on CD56 in multiple myeloma.The... read more
February 2, 2023
Researchers Identify New Drug Candidates to Treat DLST+ Tumors
The increased expression of DLST has recently been associated with increased tumor aggression and a... read more
January 19, 2023
Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia
Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined... read more
January 4, 2023
Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev?
In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more
December 8, 2022
New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers
Researchers published a research perspective about a recent study that uncovered FSP1 as a novel... read more
November 2, 2022
Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer
Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more
October 19, 2022
CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy
In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more
October 7, 2022
How High Altitudes Influence HIF-1, Gastric Cancer & Patient Survival
In a new study, researchers evaluated the high altitude in Ecuador and how it may... read more
September 27, 2022